We are live on ! Find out more
RXD icon

ProShares UltraShort Health Care
RXD

3 hedge funds and large institutions have $569K invested in ProShares UltraShort Health Care in 2019 Q2 according to their latest regulatory filings, with 1 funds opening new positions, 2 increasing their positions, 0 reducing their positions, and 1 closing their positions.

New
Increased
Maintained
Reduced
Closed

198% more call options, than puts

Call options by funds: $11.6M | Put options by funds: $3.87M

0% more funds holding

Funds holding: 3 → 3 (0)

0% more first-time investments, than exits

New positions opened: 1 | Existing positions closed: 1

7.87% less ownership

Funds ownership: 32.04% → 24.17% (-7.9%)

68% less capital inflows, than outflows

Capital inflows: $86.4K | Capital outflows: $273K

Holders
3
Holders Change
–
Holders Change %
0%
% of All Funds
0.06%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
1
Increased
2
Reduced
–
Closed
1
Calls
$11.6M
Puts
$3.87M
Net Calls
+$7.68M
Net Calls Change
+$2.78M

Top Buyers

Rank Fund Capital Flow
1
Citadel Advisors
Citadel Advisors
Florida
+$63.1K
2
BNP Paribas Financial Markets
BNP Paribas Financial Markets
France
+$12.2K
3
UBS Group
UBS Group
Switzerland
+$11.1K

Top Sellers

Rank Fund Capital Flow
1
Susquehanna International Group
Susquehanna International Group
Pennsylvania
-$273K

RXD Hedge Fund Activity: Q2 2019 in Review

3 of the 4,626 institutional investors tracked by Wall St. Rank reported a position in ProShares UltraShort Health Care (RXD) for Q2 2019, worth a combined $569K — down 27% from $776K a quarter earlier.

Fund positioning in RXD was balanced in Q2 2019: 1 fund opened new positions, 1 closed out, 2 added to existing stakes and 0 trimmed.

The largest buyer was Citadel Advisors, adding an estimated $63.1K. The largest seller was Susquehanna International Group, exiting entirely with an estimated $273K sold.

  • 3 institutional investors held ProShares UltraShort Health Care (RXD) as of Q2 2019, unchanged from Q1 2019.
  • Funds reported $569K of ProShares UltraShort Health Care stock for Q2 2019, down 27% quarter-over-quarter.
  • 1 fund opened new ProShares UltraShort Health Care positions in Q2 2019 and 1 closed out, a net change of 0 holders.
  • The largest ProShares UltraShort Health Care buyer in Q2 2019 was Citadel Advisors, an estimated $63.1K added.
  • The largest ProShares UltraShort Health Care seller in Q2 2019 was Susquehanna International Group, an estimated $273K sold.

Based on aggregated 13F filings for Q2 2019.